mRNA-1653
Showing 26 - 50 of 784
SARS-CoV-2 Trial in United States (mRNA-1283, mRNA-1273, Placebo)
Active, not recruiting
- SARS-CoV-2
- mRNA-1283
- +2 more
-
Chandler, Arizona
- +4 more
Sep 22, 2022
Relapsed or Refractory Multiple Myeloma Trial in Canada, United States (mRNA-2736)
Not yet recruiting
- Relapsed or Refractory Multiple Myeloma
- mRNA-2736
-
Birmingham, Alabama
- +12 more
Jun 15, 2023
Healthy Volunteers Trial in United Kingdom (mRNA-1769, Placebo)
Recruiting
- Healthy Volunteers
- mRNA-1769
- Placebo
-
Bradford, United Kingdom
- +11 more
Aug 18, 2023
Emergency Department (SPEED)
Not yet recruiting
- Respiratory Tract Infections
- +5 more
- IMX-BVN-4 and IMX-SEV-4
- (no location specified)
Nov 28, 2022
COVID-19, COVID-19 Immunisation Trial in Decatur, Bethesda, Seattle (mRNA-1273)
Completed
- COVID-19
- COVID-19 Immunisation
- mRNA-1273
-
Decatur, Georgia
- +2 more
Jan 26, 2023
COVID-19 Infection Trial in Turkey (Taking biological samples (blood) and keeping records with phone calls)
Active, not recruiting
- COVID-19 Infection
- Taking biological samples (blood) and keeping records with phone calls
-
Ankara, Turkey
- +7 more
May 16, 2023
SARS-CoV-2 Infection Trial in Dengfeng, Zhengzhou (COVID-19 mRNA Vaccine (ZSVG-02-O), COVID-19 Vaccine (Vero Cell) ,Inactivated)
Recruiting
- SARS-CoV-2 Infection
- COVID-19 mRNA Vaccine (ZSVG-02-O)
- COVID-19 Vaccine (Vero Cell) ,Inactivated
-
Dengfeng, Henan, China
- +1 more
Nov 6, 2023
HIV-1-infection Trial in Kigali, Johannesburg (eOD-GT8 60mer mRNA Vaccine (100µg))
Active, not recruiting
- HIV-1-infection
- eOD-GT8 60mer mRNA Vaccine (100µg)
-
Kigali, Rwanda
- +1 more
Sep 9, 2022
Respiratory Syncytial Virus Trial in United States (Placebo, mRNA-1345, Afluria® Quadrivalent)
Active, not recruiting
- Respiratory Syncytial Virus
- Placebo
- +3 more
-
Birmingham, Alabama
- +61 more
Dec 5, 2022
Hiv Trial in United States (V3G CH848 Pr-NP1 60mcg, 3M-052-AF 5mcg, Alum 500 mcg)
Not yet recruiting
- Hiv
- V3G CH848 Pr-NP1 60mcg
- +5 more
-
Birmingham, Alabama
- +5 more
Jun 5, 2023
Influenza Trial in United States (mRNA-1010, mRNA-1010.4, mRNA-1010.6)
Recruiting
- Influenza
- mRNA-1010
- +2 more
-
Hollywood, Florida
- +9 more
May 11, 2023
Influenza, Influenza Immunization Trial in United States (Influenza Hemagglutinin mRNA vaccine, Quadrivalent Recombinant
Completed
- Influenza
- Influenza Immunization
- Influenza Hemagglutinin mRNA vaccine
- Quadrivalent Recombinant Influenza Vaccine
-
Rolling Hills Estates, California
- +19 more
Oct 31, 2023
Adenoid Cystic Carcinoma, Metastatic Adenoid Cystic Carcinoma, Recurrent Adenoid Cystic Carcinoma Trial in United States
Not yet recruiting
- Adenoid Cystic Carcinoma
- +2 more
-
San Francisco, California
- +5 more
Nov 1, 2023
Cytomegalovirus Trial in Canada, United Kingdom, United States (mRNA-1647, Placebo)
Recruiting
- Cytomegalovirus
- mRNA-1647
- Placebo
-
La Mesa, California
- +60 more
Jan 12, 2023
Healthy, Chronic Stable Illness Trial in United States (casirivimab+imdevimab, Moderna mRNA-1273 vaccine)
Completed
- Healthy
- Chronic Stable Illness
- casirivimab+imdevimab
- Moderna mRNA-1273 vaccine
-
Little Rock, Arkansas
- +5 more
Jan 9, 2023
Genital Herpes Trial in United States (mRNA-1608, BEXSERO)
Recruiting
- Genital Herpes
- mRNA-1608
- BEXSERO
-
Birmingham, Alabama
- +24 more
Sep 11, 2023
Papillomavirus Infections, Coronavirus Disease (COVID-19) Trial in United States (9vHPV Vaccine, mRNA-1273 Vaccine)
Recruiting
- Papillomavirus Infections
- Coronavirus Disease (COVID-19)
- 9vHPV Vaccine
- mRNA-1273 Vaccine
-
Phoenix, Arizona
- +37 more
Jan 18, 2023
SARS-CoV-2 Trial in Atlanta, Seattle (mRNA-1273)
Active, not recruiting
- SARS-CoV-2
- mRNA-1273
-
Mesa, Arizona
- +14 more
Aug 31, 2022
COVID Vaccine Immunity in Kidney Transplant Recipients
Withdrawn
- End Stage Renal Disease
- Kidney Transplant; Complications
- Coronavirus (COVID-19) SARS-CoV-2 inSIGHT™ T Cell Immunity Test
- (no location specified)
Oct 25, 2022
Digestive System Tumors Trial in Hangzhou (iNeo-Vac-R01)
Recruiting
- Digestive System Neoplasms
- iNeo-Vac-R01
-
Hangzhou, Zhejiang, ChinaDepartment of General Surgery, Institute of Minimally Invasive S
Sep 8, 2023
Angiosarcoma Trial in Houston (Paclitaxel, mRNA plus Lysate-loaded Dendritic Cell Vaccine, PEGYLATED-INTERFERON ALPHA-2A)
Not yet recruiting
- Angiosarcoma
- Paclitaxel
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Mar 23, 2023
Seasonal Influenza Trial in Argentina, Australia, Colombia (mRNA-1010, Licensed quadrivalent inactivated seasonal influenza
Active, not recruiting
- Seasonal Influenza
- mRNA-1010
- Licensed quadrivalent inactivated seasonal influenza vaccine
-
Buenos Aires, Argentina
- +52 more
Sep 19, 2022